Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Return on Assets (2016 - 2025)

Historic Return on Assets for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Q3 2025 value amounting to 0.28%.

  • Enanta Pharmaceuticals' Return on Assets rose 200.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.25% for FY2025, which is 300.0% up from last year.
  • According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Return on Assets is 0.28%, which was up 200.0% from 0.29% recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Return on Assets high stood at 0.19% for Q1 2021, and its period low was 0.37% during Q1 2023.
  • Its 5-year average for Return on Assets is 0.29%, with a median of 0.29% in 2024.
  • As far as peak fluctuations go, Enanta Pharmaceuticals' Return on Assets tumbled by -2300bps in 2021, and later skyrocketed by 600bps in 2024.
  • Over the past 5 years, Enanta Pharmaceuticals' Return on Assets (Quarter) stood at 0.26% in 2021, then fell by -28bps to 0.33% in 2022, then increased by 7bps to 0.31% in 2023, then increased by 7bps to 0.29% in 2024, then rose by 3bps to 0.28% in 2025.
  • Its Return on Assets stands at 0.28% for Q3 2025, versus 0.29% for Q2 2025 and 0.29% for Q1 2025.